Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.

Literature DB >> 21960800

Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.

Adam Harris, Shanti Eswaran, Brian Bosworth, Maya Gambarin-Gelwan, Ellen J Scherl.

Abstract

Entities: Chemical Disease

Year: 2007 PMID： 21960800 PMCID： PMC3104150

Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN： 1554-7914

× No keyword cloud information.

23 in total

1. Oral desensitization to 5-ASA.

Authors: S Varela; M S Díez; C Gonzalez; C Gonzalez de la Cuesta; L Arenas; R Feijoó; M Menéndez
Journal: Allergy Date: 2002-04 Impact factor: 13.146

Review 2. Inflammatory bowel disease.

Authors: Daniel K Podolsky
Journal: N Engl J Med Date: 2002-08-08 Impact factor: 91.245

Review 3. Extraintestinal manifestations in inflammatory bowel disease.

Authors: Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal: World J Gastroenterol Date: 2005-12-14 Impact factor: 5.742

Review 4. Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine.

Authors: P Sossai; M G Cappellato; S Stefani
Journal: Mt Sinai J Med Date: 2001-11

5. Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine.

Authors: G Haralambou; A S Teirstein; J Gil; D H Present
Journal: Mt Sinai J Med Date: 2001-11

6. Once-daily, high-concentration MMX mesalamine in active ulcerative colitis.

Authors: Michael A Kamm; William J Sandborn; Miguel Gassull; Stefan Schreiber; Lechoslaw Jackowski; Todd Butler; Andrew Lyne; David Stephenson; Mary Palmen; Raymond E Joseph
Journal: Gastroenterology Date: 2006-10-12 Impact factor: 22.682

7. Adverse pulmonary effects of mesalamine.

Authors: A Muzzi; F Ciani; D Bianchini; G Festini; C Volpe
Journal: Chest Date: 1995-10 Impact factor: 9.410

8. Mesalazine-associated interstitial nephritis.

Authors: M J World; P E Stevens; M A Ashton; D J Rainford
Journal: Nephrol Dial Transplant Date: 1996-04 Impact factor: 5.992

9. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.

Authors: R A J Ransford; M J S Langman
Journal: Gut Date: 2002-10 Impact factor: 23.059